Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease

What is Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease ?

Vetmedin®-CA1 (pimobendan) chewable tablets is conditionally approved for the treatment of dogs with myxomatous mitral valve disease (MMVD) in the pre-clinical stage B2 (asymptomatic with a murmur/abnormal heart sounds and evidence of increased heart size) to delay onset of clinical signs of heart failure. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-556 (please see full prescribing information). Given every 12 hours, the unique dual action of VETMEDIN®-CA1 dilates the blood vessels carrying blood to and from the heart—reducing the overall load on the heart—while simultaneously improving the ability of the heart muscle to contract. The active ingredient in VETMEDIN®-CA1 (pimobendan) helps the heart muscle to contract and relax (pump) more effectively and it dilates blood vessels which reduces the amount of force with which the heart needs to pump blood.

Suitable for:

Dogs (with Myxomatus Mitral Valve Disease)

Benefits:

• Recommended for dogs diagnosed with Stage B2 MMVD, VETMEDIN®-CA1 (pimobendan) can be used for the delay of onset of congestive heart failure.
• May prolong the number of symptom-free days in dogs.
• VETMEDIN®-CA1 helps dogs continue to engage in the daily activities they enjoy.
• Available as a beef-flavored, chewable tablet in 2 convenient dosing sizes (1.25 mg and 5 mg).

How does Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease work?

Vetmedin®-CA1 (pimobendan) chewable tablets are indicated for the delay of onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease (2019 ACVIM Consensus Statement1 ).

Caution:

Observe good industrial hygiene practices. Wash hands after handling.

How should I store this product?

Store in a cool, dry place.

What is the most important information I should know about Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease ?

For dogs with valvular insufficiency it extends life and improves quality of life.

What should I discuss with my veterinarian before giving Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease to my pet?

If there is a prescription for Vetmedin CA-1, there should be no questions. If there is no prescription, they should ask if their dog is a candidate for Vetmedin CA-1. VETMEDIN®-CA1 should be given to your dog once a veterinarian has confirmed that it meets the criteria for Stage B2 preclinical myxomatous mitral valve disease.

How should Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease be given/administered?

Give by mouth as prescribed.

What are the potential side effects of Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease ?

The most common side effects seen in dogs with Stage B2 MMVD while taking VETMEDIN®-CA1 Chewable Tablets are cough, vomiting, diarrhea, lethargy (lack of energy), and localized pain (such as in the neck or legs). If side effects occur, consult your veterinarian. 

What happens if I miss giving a dose of Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease ?

If a dose of VETMEDIN®-CA1 is missed give the next scheduled dose at the normal time. There’s no need to give a higher dose.

What happens if I overdose my pet on Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease ?

Call your veterinarian.

What should I avoid while giving Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease to my pet?

Do not give to dogs with a hypersensitivity to fluoxetine hydrochloride. Do not give to dogs that are pregnant, breeding, or nursing or puppies under 6 months old.

What other drugs will affect Vetmedin-CA1 (pimobendan) - Chewable Tablets for Dogs with Stage 2 Mitral Valve Disease ?

There are no known adverse drug interactions